An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic

<scp>CHARMM</scp>: A program for macromolecular energy, minimization, and dynamics calculations

1983 • 14,615 citations

A small molecule–kinase interaction map for clinical kinase inhibitors

2005 • 1,854 citations

Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase

2000 • 1,770 citations

Tyrosine Kinase Inhibition: An Approach to Drug Development

1995 • 1,655 citations

Simulation of activation free energies in molecular systems

1996 • 1,279 citations

Quantum and statistical mechanical studies of liquids. 10. Transferable intermolecular potential functions for water, alcohols, and ethers. Application to liquid water

1981 • 1,210 citations

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

2006 • 1,156 citations

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate

2006 • 1,126 citations

Catalytic specificity of protein-tyrosine kinases is critical for selective signalling

1995 • 929 citations

STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

2001 • 698 citations

Features of Selective Kinase Inhibitors

2005 • 625 citations

Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase

2004 • 598 citations

Issues and progress with protein kinase inhibitors for cancer treatment

2003 • 529 citations

Evidence for In Vivo Phosphorylation of the Grb2 SH2-Domain Binding Site on Focal Adhesion Kinase by Src-Family Protein-Tyrosine Kinases

1996 • 450 citations

Solvent effects on protein motion and protein effects on solvent motion

1989 • 409 citations

STRESS signaling pathways that modulate cardiac myocyte apoptosis

2004 • 334 citations

Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces Apoptosis

1997 • 325 citations

Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation

1998 • 271 citations

Insufficiently dehydrated hydrogen bonds as determinants of protein interactions

2002 • 254 citations

Characterization of pp60c-src Tyrosine Kinase Activities Using a Continuous Assay: Autoactivation of the Enzyme Is an Intermolecular Autophosphorylation Process

1995 • 192 citations

The GIST of targeted cancer therapy: A tumor (Gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571)

2002 • 145 citations

Pharmaceutical research in molecular oncology

1994 • 134 citations

The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.

2002 • 133 citations

TYROSINE KINASE INHIBITORS AND THE DAWN OF MOLECULAR CANCER THERAPEUTICS

2004 • 118 citations

Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies

2003 • 114 citations

Molecular Remissions Induced by Liposomal-Encapsulated All-Trans Retinoic Acid in Newly Diagnosed Acute Promyelocytic Leukemia

1999 • 106 citations

Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: Analyis of EORTC-ISG-AGITG study 62005

2007 • 100 citations

Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase

2001 • 90 citations

Contractile activity modulates myosin heavy chain-beta expression in neonatal rat heart cells

1991 • 72 citations

Molecularly Targeted Therapy: Have the Floodgates Opened?

2004 • 55 citations

A new model of congestive heart failure in the mouse due to chronic volume overload

2001 • 52 citations

Molecular basis for specificity in the druggable kinome: sequence-based analysis

2007 • 47 citations

Establishment of a mouse gastrointestinal stromal tumour model and evaluation of response to imatinib by small animal positron emission tomography.

2006 • 40 citations